Skip to content

Astrin Biosciences Earns CAP Accreditation for Breast Cancer Blood Test

Release Date: 25 Apr 2026 CLP
cap

Astrin Biosciences has received accreditation from the College of American Pathologists (CAP) Accreditation Committee following an on-site inspection of its facility in St Paul, Minnesota. The achievement follows the launch of Certitude Breast, a non-imaging blood test designed to identify early molecular signals associated with breast cancer.

For the full article click here: Astrin Biosciences Earns CAP Accreditation for Breast Cancer Blood Test

adding all to cart
False 0
File added to media cart.